Coronary artery disease and TAVI: Current evidence on a recurrent issue.
Mauro MassussiMarianna AdamoFabrizio RosatiGiuliano ChizzolaMarco MetraFrancesco CardaioliPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2023)
Coronary artery disease (CAD) is a frequent finding in patients with aortic stenosis (AS). Concomitant coronary artery bypass and aortic valve replacement is considered the gold standard treatment in surgical candidates. However, limited evidence is available regarding the role of coronary revascularization in patients undergoing transcatheter aortic valve implantation (TAVI). How to evaluate CAD severity in patients with AS, whether percutaneous coronary intervention (PCI) needs to be performed and what is the timing for revascularization to minimize procedural risks, remains matters of debate. The aim of this review is to summarize epidemiology, diagnostic tools and possible options for CAD management in patients undergoing TAVI with specific focus on the pros and the cons of the different timing of PCI.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- coronary artery bypass
- patients undergoing
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- cardiovascular events
- transcatheter aortic valve replacement
- aortic valve
- ejection fraction
- acute coronary syndrome
- type diabetes
- risk factors
- heart failure
- human health
- combination therapy